On the Pawsindia pitch in Shark Tank India, Season 1, Episode 25, I questioned the company’s business mix and strategic focus. Priyam Singh’s business claims and the other Sharks’ remarks are distinguished from my own views. I declined to proceed with an offer and said I wanted to exit.
I spoke as a shark during the Pawsindia pitch on Shark Tank India, Season 1, Episode 25.
Priyam Singh said 90% own brand; 10% other brands.
Priyam Singh said healthcare represented 25% of own-brand sales; many products were still in prototype stage.
Priyam Singh reported 20 lakhs sales; net revenue 16.5, 16.75, something like that.
Priyam Singh reported 1.2 CR so far that year; 1.2 CR previous full year; target 3 crore that year.
Priyam Singh described the bone product as having eight SKUs; exclusive distribution rights.
Priyam Singh said, “B2B bhi hai aur B2C bhi hai,” describing the business model as both B2B and B2C.
I described Pawsindia as a small 2 crore company trying to run four models would not build a business.
I assessed that marketplace and additional activities were weaknesses, not strengths.
I contrasted Pawsindia’s breadth with Heads Up For Tails, describing the latter as focused on selling a fun brand to dog and cat owners, while Pawsindia also sold 50-60 items to vets.
I said I had been about to offer 50 lakh for 10%, but called the pharmaceutical venture a major distraction and said I wanted to exit. The transcript does not show me making that offer.
I challenged the rationale for selling other brands, saying their margins would be lower and asking why the founders were spending time on it. I also rejected retailer and distributor requests as sufficient reason to expand: asking for a pen does not mean one should start making pens.
I had expected a focused B2C dog brand, and argued that too many models and product categories in a small company could keep the founders from building a business. No investment terms were agreed in the transcript.
Priyam Singh described the company as a marketplace that also developed its own branded products, with other small companies joining over time. He said the remaining own-brand revenue came from accessories, tech toys, edible items, and dog food.
I probed the business mix by asking about own-brand versus other-brand contribution and total revenue. I asked to see the products, then asked about last month’s revenue and whether the 20 lakhs figure was sales or net revenue. The transcript leaves unresolved the apparent difference between the reported sales and net-revenue figures, the detailed category-level revenue and margins, and the other Sharks’ discussion outcome.
Priyam Singh said he had worked in investment banking at JP Morgan before joining Pawsindia.
Priyam Singh said his co-founder had been in the pharmaceutical business for a very long time and that his father’s company, Pramo Life Science, manufactured and exported in the African market.
I said Pawsindia had asked for a valuation of saade baarah crore.